Eli Lilly & Co. (NYSE:LLY) | Eli Lilly & Co.: Big Pharma Checkup for 2014

[at Motley Fool] – The patent cliff hits Eli Lilly (LLY) hard in 2014. Here’s how Lilly hopes to survive the sales headwind and compete against AstraZeneca (AZN), Novo Nordisk (NVO) and Sanofi . . . → Read More: Eli Lilly & Co. (NYSE:LLY) | Eli Lilly & Co.: Big Pharma Checkup for 2014

Eli Lilly & Co. (NYSE:LLY) [at Motley Fool] – The patent cliff hits Eli Lilly (LLY) hard in 2014. Here’s how Lilly hopes to survive the sales headwind and compete against AstraZeneca (AZN), Novo Nordisk (NVO) and Sanofi (SNY)
Read more on this.

… [visit site to read more]

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.